Filter
1177
Filtered Results: 1177
Text search:
J.-J.
Kim
Featured
Recommendations
108
New Publications
184
Language
Document type
No document type
564
Studies & Reports
258
Guidelines
198
Manuals
59
Fact sheets
43
Strategic & Response Plan
29
Training Material
19
Situation Updates
3
Infographics
3
Brochures
1
Countries / Regions
Global
52
Kenya
44
Russia
34
India
31
Indonesia
25
South Africa
23
Brazil
23
Western and Central Europe
21
Tanzania
17
Latin America and the Carribbean
16
Germany
15
Mozambique
15
Eastern Europe
15
Middle East and North Africa
14
Africa
13
Congo, Democratic Republic of
12
Rwanda
12
Ukraine
12
Malawi
11
Uganda
10
Syria
10
Argentina
10
Asia
10
Cambodia
9
Yemen
9
Senegal
8
Ethiopia
8
Haiti
8
Nepal
8
Angola
8
Philippines
7
Lesotho
7
Burkina Faso
6
Guinea-Bissau
6
Ghana
6
Zambia
6
Bangladesh
6
Colombia
6
Myanmar / Burma
6
South–East Asia Region
6
Eastern Europe and Central Asia
6
Liberia
5
USA
5
Zimbabwe
5
South Sudan
5
Sierra Leone
4
Thailand
4
Botswana
4
Venezuela
4
Mali
3
Sudan
3
Benin
3
Peru
3
Ecuador
3
Chile
3
West and Central Africa
3
Laos
3
Vietnam
3
Jamaica
3
Portugal
3
Guinea
2
Nigeria
2
Côte d’Ivoire / Ivory Coast
2
Cameroon
2
Jordan
2
Namibia
2
Eswatini/ Swaziland
2
Mexico
2
Western Pacific Region
2
Spain
2
Morocco
1
Togo
1
Somalia
1
Pakistan
1
Afghanistan
1
Lebanon
1
Turkey
1
Egypt
1
Singapore
1
Papua New Guinea
1
North Macedonia
1
Hungary
1
Honduras
1
Bolivia
1
Sri Lanka
1
East and Southern Africa
1
Paraguay
1
Armenia
1
Mongolia
1
Southern Africa
1
Canada
1
Kyrgyzstan
1
Georgia
1
North America
1
France
1
Norway
1
Authors & Publishers
Publication Years
Category
Countries
351
Clinical Guidelines
96
Women & Child Health
73
Public Health
69
Key Resources
24
Pharmacy & Technologies
9
Capacity Building
5
Toolboxes
COVID-19
202
Mental Health
141
HIV
108
TB
106
Planetary Health
62
NCDs
38
Caregiver
30
Disability
23
NTDs
22
AMR
21
Ebola
20
Refugee
19
Global Health Education
19
Pharmacy
15
Rapid Response
14
Natural Hazards
13
Conflict
11
Health Financing Toolbox
11
Cholera
9
Polio
7
Zika
4
Specific Hazards
4
Social Ethics
3
Health Financing
1
WHO‘s Global Strategy to Accelerate the Elimination of Cervical Cancer, launched today, outlines three key steps: vaccination, screening and treatment. Successful implementation of all three could reduce more than 40% of new cases of the disease and 5 million related deaths by 2050.
Measuring progress towards universal health coverage.
This sixth edition of Health at a Glance Asia/Pacific presents a set of key indicators of health status, the determinants of health, health care resources and utilisation, health care expenditure and financing and quality of care across 27 Asia-...
Epidemiologisches Bulletin3 | 202121. Januar 2021 (online vorab)
Increasing the Odds: A Series to Understanding Gambling Disorders. Vol.7
All editions of Increasing the Odd sare available as a free download at https://www.icrg.org/resources/monographs
MOH clinical practice guidelines
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
The WHO Regional Office for Europe has established the Childhood Obesity Surveillance Initiative in more than half the countries in the Region for routine monitoring of the policy response to the emerging obesity epidemic. The aim of the Initiative is to measure trends in overweight and obesity in c...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w...
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
Interim guidance 2 February 2021 . Available in Arabic, Chinese, English, French, Ukranian, Russian
Health workers are at the front line of the COVID-19 outbreak response and as such are exposed to different hazards that put them at risk. Occupational hazards include exposure to SARS-CoV-2 and othe...
Änderung gegenüber der Version vom 26.1.2021: Aktualisierung der Informationen über monoklonale Antikörper und Rekonvaleszentenplasma
VOX Sanguinis, 2021:
The coronavirus disease 2019 (COVID-19) affected millions of people worldwide and caused disruptions at the global level including in healthcare provision. Countries of the WHO African region have put in place measures for the COVID-19 pandemic containment that may adversely a...
ПРАКТИЧЕСКИЕ ШАГИ ПО ОБЕСПЕЧЕНИЮ ВСЕОБЩЕГО ДОСТУПА К КАЧЕСТВЕННОЙ ПОМОЩИ
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic...
